Synerkine Pharma
PrivateLast Round
Series A
Extension
Oct 12, 2023
Total Funding Raised
$20.52M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Synerkine Pharma operates in Healthcare & Life Sciences and is based in Leiden. Its latest recorded funding round was a Series A Extension round in October 2023.
Synerkine Pharma is a biopharmaceutical company that develops a class of biologics, called Synerkines, for the treatment of chronic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Synerkine Pharma Comparables
Compare Synerkine Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Ambros Therapeutics, Inc. | 75% | |
| Xalud Therapeutics | 70% | |
| BRC Therapeutics | 68% |
For institutional investors. Book with your work email.
Synerkine Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Oct 12, 2023 | ||||
| Series A Extension | Dec 16, 2021 | ||||
| Series A | Mar 25, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Synerkine Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Thuja Capital | Series A Extension, Series A |
| InnovationQuarter | Series A Extension |
| Flerie AB | Series A Extension |
| Utrecht Holdings | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 227% MoM.
- Oct 12, 2023
$13M round led by Flerie AB.
For institutional investors. Book with your work email.
Synerkine Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Synerkine Pharma's valuation, stock price, and market status.
Is Synerkine Pharma a public or private company?
Synerkine Pharma is a private company.
What is the current stock price of Synerkine Pharma?
Synerkine Pharma is a private company, so its shares have no public market price. Caplight tracks Synerkine Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Synerkine Pharma worth (valuation)?
Valuation information for Synerkine Pharma is not publicly available.
Can I buy Synerkine Pharma stock?
Synerkine Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Synerkine Pharma's last funding round?
Synerkine Pharma's most recent funding round was Series A Extension on October 12, 2023.
Who are the main investors in Synerkine Pharma?
Key investors in Synerkine Pharma include Thuja Capital, Flerie AB.
Will Synerkine Pharma IPO soon?
No public IPO plans have been announced for Synerkine Pharma.
How can I track Synerkine Pharma secondary market activity?
Caplight tracks bids, offers, and trades in Synerkine Pharma's shares on secondary markets.